Seoul City Teams Up with Celltrion and Daewon Pharmaceutical to Nurture Bio Startups
Open Innovation Startups Selected
Joint Research and Commercialization Support Planned
Infrastructure Support Including Overseas Networking
On June 10, the Seoul Metropolitan Government announced that it will collaborate with Celltrion and Daewon Pharmaceutical to nurture promising bio startups in Seoul. The city plans to conduct joint research with the bio startups that were finally selected for this year's open innovation program and will provide support through to commercialization.
A total of four bio startups have been chosen to collaborate with Celltrion. "AinB," which has an artificial intelligence (AI)-based protein antibody development platform, and "Enbiocell," which is developing a technology to formulate GLP-1 derivatives—regarded as next-generation treatments for obesity and diabetes—into oral pills, were selected. "ImitaScience," another selected company, possesses biomimetic multi-organ chip technology that can replace animal testing. "Podotherapeutics" has established a precision medical platform that verifies individual drug responses using patient-derived organoids (mini organs).
On the 10th, attendees are taking a commemorative photo at the 'Seoul Bio Hub-Celtrion Open Innovation Selected Companies Agreement Ceremony' held at the Celtrion Global Biotechnology Research Center in Songdo, Incheon. Seoul City
View original imageIn the case of Daewon Pharmaceutical, it will work with "Omniamed," which has a technology that selectively activates drugs only in inflamed and cancerous tissues, and "Curiosa Bioscience," which has developed technology to control drug release at the molecular level.
Celltrion and Daewon Pharmaceutical will consider technology validation and joint research and development with these bio startups. They will also help the startups further refine their development and commercialization strategies. The city will provide support such as research and office space and laboratory equipment by utilizing "Seoul Bio Hub" near Hongneung in Dongdaemun-gu. In addition, public infrastructure support, such as overseas networking, will be linked to help promising startups establish themselves in the market.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Lee Sooyeon, Director-General for Economy at the Seoul Metropolitan Government, stated, "For startups, this will be an opportunity to inherit the experience and network of global anchor companies, and for large corporations, it will be a platform to secure innovative technologies for mutual growth. We will spare no effort to support the selected promising startups so that they can grow into unicorn companies leading the global bio market, beyond South Korea."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.